covidvaccine
Moderna and Pfizer are now testing their COVID vaccines against the new strain that has emerged in the U.K. and other countries. The U.S. Centers for Disease Control and Prevention said today that the new strain has not been detected in the U.S. Q3 2020 hedge fund letters, conferences and more However, it also said that just a small faction of infections in the country have been sequenced, which means the new strain could be in the U.S. "without having been detected." The CDC also said that travel between the U.K. and the U.S. and the widespread prevalence of the new strain in the U.K. increas...
ValueWalk
The U.S. Food and Drug Administration (FDA) has officially endorsed Pfizer and BioNTech’s COVID vaccine. That paves the way for emergency use authorization as the agency moves quickly to make the first coronavirus vaccine available in the U.S. Q3 2020 hedge fund letters, conferences and more FDA endorses Pfizer/ BioNTech's COVID vaccineFDA Commissioner Dr. Stephen Hahn and Dr. Peter Marks, director of the agency's Center for Biologics Evaluation and Research, said they will now "rapidly work toward finalization and issuance of an emergency use authorization" for Pfizer and BioNTech's COVID vac...
ValueWalk
After clinical trials showed no major side effects with Pfizer’s COVID vaccine, the U.K. is attaching a new warning after severe allergic reactions in two patients who were among the first to receive it outside the clinical trial. Q3 2020 hedge fund letters, conferences and more Warning issued for Pfizer's COVID vaccineThe warning is for patients with a history of "significant" allergic reactions to food, vaccines or medications, who are advised not to get Pfizer's COVID vaccine. According to CNN, the two patients who received the vaccine were healthcare workers in the U.K. They developed an a...
ValueWalk
Pfizer and BioNTech have applied for approval for their COVID vaccine in Europe. The application is for conditional marketing authorization. BioNTech said if the European Medicines Agency (EMA) approves their application, Pfizer’s COVID vaccine could start being distributed in Europe this month.Pfizer, BioNTech seek approval for COVID vaccine in EuropeThe EMA said on its website that authorization is needed for medicines “that address unmet medical needs of patients on the basis of less comprehensive data than normally required.” The agency also said companies can apply for conditional marketi...
ValueWalk
AstraZeneca and the University of Oxford have announced the results of the late-stage clinical trials for its COVID vaccine. The headline effective rate is only 70%, but there’s much more to the story. In reality, AstraZeneca’s COVID vaccine could be more promising than the candidates from Pfizer and Moderna.Q3 2020 hedge fund letters, conferences and moreLate-stage results for AstraZeneca's COVID vaccineWhat makes AstraZeneca's COVID vaccine trials so different than the trials conducted by Pfizer and Moderna is the fact that the company tried two different dosing regimens. The average effecti...
ValueWalk
First on CNBC: CNBC Transcript: Moderna CEO Stephane Bancel speaks with CNBC’s “Squawk Box” today on their 94.5% effective Covid vaccineQ3 2020 hedge fund letters, conferences and moreModerna CEO Stephane Bancel on its 94.5% effective Covid vaccine: We hope to get it to market soonAll references must be sourced to CNBC.BECKY QUICK: All right, listen up everybody some breaking news from Moderna. Meg Tirell joins us right now with the headlines and special guest, Meg, take it away.MEG TIRRELL: Hi Becky well we're getting Moderna is phase three interim results 94.5% advocacy for their COVID-19 va...
ValueWalk
Commenting on Eli Lilly’s antibody treatment being halted and today’s trading, Gorilla Trades strategist Ken Berman said:Q3 2020 hedge fund letters, conferences and moreEli Lilly's Antibody Treatment HaltedThe major indices are mixed and flat at midday following a choppy and nervous morning session on Wall Street. The financial sector was in focus with regards to earrings for the second day in a row this morning and today’s reports were much weaker than yesterday’s ones. Bank of America (BAC, -4.1%) missed on its top line, while Wells Fargo (WFC, -5.0%) reported bearish earnings, with only Gol...
ValueWalk
閲覧を続けるには、ノアドット株式会社が「プライバシーポリシー」に定める「アクセスデータ」を取得することを含む「nor.利用規約」に同意する必要があります。
「これは何?」という方はこちら